The global population screening market size is expected to reach USD 38.2 billion by 2030. The market is expected to expand at a CAGR of 5.36% from 2023 to 2030. The growth of the market is attributed to the increasing prevalence of diseases, the growing geriatric population, and increasing investment in population screening tests. Moreover, the market is expected to be driven significantly by increasing technological advancements and developments in these tests. ![Global Population Screening Market]( "Global Population Screening Market")
An increase in the prevalence of cardiovascular diseases is expected to boost segment growth. According to the WHO, 17.7 million people die annually due to cardiovascular diseases, which is 31.0% of the total deaths occurring worldwide. Cardiovascular diseases are the leading cause of mortality and morbidity in the U.S. They are among the main causes of death globally, and hypertension & its pathological adverse effects pose a significant risk for other cardiac diseases, such as heart failure & stroke. There are multiple screening programs available for material fibrillation globally that aim to reduce the mortality rate. Identifying early-stage hypertension and other CVDs is of high significance in predicting & preventing major mortality & morbidity related to these diseases.
The growing prevalence of rare genetic diseases such as Spinal Muscular Atrophy (SMA) disorders and increased spending on population screening are among the major factors for the dominance of the market. According to the National Organization for Rare Disorders (NORD), SMA affects almost one in 10,000 people globally. In addition, according to SMA Canada, approximately 700 people were living with this condition in Canada as of July 2022. For instance, the CDC released the Recommended Uniform Screening Panel (RUSP) to states under its statewide universal newborn programs for the early identification of children with SMA. Thus, such initiatives are undertaken by governments to screen the population, thereby supporting the growth of the population screening market.
Players in the market adopt the strategy of product launches to strengthen their product portfolio and offer diverse, technologically advanced, & innovative population screening products to patients. Several market players engage in mergers & acquisitions to strengthen their market position. This strategy enables companies to boost their capabilities, expand product portfolios, and improve competencies. For instance, in August 2022, Thermo Fisher Scientific, Inc., launched an HIV-1 genotyping kit to identify the genetic mutations that resist Antiretroviral Therapeutics (ART). This kit was intended only for research purposes.
An increase in the prevalence of cardiovascular diseases is expected to boost segment growth. According to the WHO, 17.7 million people die annually due to cardiovascular diseases, which is 31.0% of the total deaths occurring worldwide. Cardiovascular diseases are the leading cause of mortality and morbidity in the U.S. They are among the main causes of death globally, and hypertension & its pathological adverse effects pose a significant risk for other cardiac diseases, such as heart failure & stroke. There are multiple screening programs available for material fibrillation globally that aim to reduce the mortality rate. Identifying early-stage hypertension and other CVDs is of high significance in predicting & preventing major mortality & morbidity related to these diseases.
The growing prevalence of rare genetic diseases such as Spinal Muscular Atrophy (SMA) disorders and increased spending on population screening are among the major factors for the dominance of the market. According to the National Organization for Rare Disorders (NORD), SMA affects almost one in 10,000 people globally. In addition, according to SMA Canada, approximately 700 people were living with this condition in Canada as of July 2022. For instance, the CDC released the Recommended Uniform Screening Panel (RUSP) to states under its statewide universal newborn programs for the early identification of children with SMA. Thus, such initiatives are undertaken by governments to screen the population, thereby supporting the growth of the population screening market.
Players in the market adopt the strategy of product launches to strengthen their product portfolio and offer diverse, technologically advanced, & innovative population screening products to patients. Several market players engage in mergers & acquisitions to strengthen their market position. This strategy enables companies to boost their capabilities, expand product portfolios, and improve competencies. For instance, in August 2022, Thermo Fisher Scientific, Inc., launched an HIV-1 genotyping kit to identify the genetic mutations that resist Antiretroviral Therapeutics (ART). This kit was intended only for research purposes.
Population Screening Market Report Highlights
- The nation segment held a dominant share of the market in 2022 owing to the effectiveness and precision offered by CTCs in the detection of cancer
- The premium segment is projected to grow at the fastest rate over the forecast period owing to the increasing dominance of private screening programs
- The female segment is the highest revenue-generating segment in 2022 owing to the increasing number of tests being performed by females
- North America dominated the population screening market in 2022, which is attributed to preventive measures undertaken by governments to stop the progression of diseases
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Secondary Sources
1.3.3 Primary Research
1.3.4 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.12 List of Abbreviations
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Secondary Sources
1.3.3 Primary Research
1.3.4 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.12 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Popular Screening Market Variables, Trends & Scope
3.1 Population Screening Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.1.1 Cellular Health Screening Market Outlook
3.1.1.2 In Vitro Diagnostics Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Driver Analysis
3.3.1 Increasing Prevalence Of Diseases
3.3.2 Growing Investments In Population Screening
3.3.3 Growing Geriatric Population
3.4 Market Restraint Analysis
3.4.1 High Cost Associated With Screening
3.4.2 Psychological Factors, Knowledge, Attitudes, And Beliefs
3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.6 Porter’s Five Forces Analysis
3.7 Regulatory Framework
3.1.1 Parent Market Outlook
3.1.1.1 Cellular Health Screening Market Outlook
3.1.1.2 In Vitro Diagnostics Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Driver Analysis
3.3.1 Increasing Prevalence Of Diseases
3.3.2 Growing Investments In Population Screening
3.3.3 Growing Geriatric Population
3.4 Market Restraint Analysis
3.4.1 High Cost Associated With Screening
3.4.2 Psychological Factors, Knowledge, Attitudes, And Beliefs
3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.6 Porter’s Five Forces Analysis
3.7 Regulatory Framework
Chapter 4 Population Screening Market - Segment Analysis, by Geography, 2018 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Population Screening Market: Geography Movement Analysis
4.2.1 Nation
4.2.1.1 Nation Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.2 State
4.2.2.1 State market estimates and forecast, 2018 - 2030 (USD Million)
4.2 Population Screening Market: Geography Movement Analysis
4.2.1 Nation
4.2.1.1 Nation Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.2 State
4.2.2.1 State market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5 Population Screening Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
5.1 Population Screening Market: Product Movement Analysis
5.1.1 Hardware Equipment (Instrument, Kits, Chips)
5.1.1.1 Hardware Equipment (Instrument, Kits, Chips) Market Estimates And Forecast, 2018 - 2030 (Usd Million)
5.1.2 Testing/Lab (Services)
5.1.2.1 Testing/Lab (Services) Market Estimates And Forecast, 2018 - 2030 (Usd Million)
5.1.3 Analytics/Interpretation (Personalization And Interpretation)
5.1.3.1 Analytics/Interpretation (Personalisation and interpretation) market estimates and forecast, 2018 - 2030 (USD Million)
5.1.1 Hardware Equipment (Instrument, Kits, Chips)
5.1.1.1 Hardware Equipment (Instrument, Kits, Chips) Market Estimates And Forecast, 2018 - 2030 (Usd Million)
5.1.2 Testing/Lab (Services)
5.1.2.1 Testing/Lab (Services) Market Estimates And Forecast, 2018 - 2030 (Usd Million)
5.1.3 Analytics/Interpretation (Personalization And Interpretation)
5.1.3.1 Analytics/Interpretation (Personalisation and interpretation) market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6 Population Screening Market - Segment Analysis, by Business, 2018 - 2030 (USD Million)
6.1 Definition and Scope
6.2 Population Screening Market: Business Movement Analysis
6.2.1 Hospitals
6.2.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.2.2 Research Institutes
6.2.2.1 Research Institutes Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.2.3 Diagnostic Labs
6.2.3.1 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Million)
6.2 Population Screening Market: Business Movement Analysis
6.2.1 Hospitals
6.2.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.2.2 Research Institutes
6.2.2.1 Research Institutes Market Estimates And Forecast, 2018 - 2030 (Usd Million)
6.2.3 Diagnostic Labs
6.2.3.1 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7 Population Screening Market - Segment Analysis, by Gender, 2018 - 2030 (USD Million)
7.1 Definition and Scope
7.2 Population Screening Market: Gender Movement Analysis
7.2.1 Male
7.2.1.1 Male Market Estimates And Forecast, 2018 - 2030 (Usd Million)
7.2.2 Female
7.2.2.1 Female market estimates and forecast, 2018 - 2030 (USD Million)
7.2 Population Screening Market: Gender Movement Analysis
7.2.1 Male
7.2.1.1 Male Market Estimates And Forecast, 2018 - 2030 (Usd Million)
7.2.2 Female
7.2.2.1 Female market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8 Population Screening Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
8.1 Definition and Scope
8.2 Population Screening Market: Type Movement Analysis
8.2.1 Mass
8.2.1.1 Mass Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 Premium
8.2.2.1 Premium market estimates and forecast, 2018 - 2030 (USD Million)
8.2 Population Screening Market: Type Movement Analysis
8.2.1 Mass
8.2.1.1 Mass Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 Premium
8.2.2.1 Premium market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9 Population Screening Market - Segment Analysis, by Age, 2018 - 2030 (USD Million)
9.1 Definition and Scope
9.2 Population Screening Market: Age Movement Analysis
9.2.1 Age < 15
9.2.1.1 Age < 15 Market Estimates And Forecast, 2018 - 2030 (USD Million)
9.2.2 15-65
9.2.2.1 15-65 Market Estimates And Forecast, 2018 - 2030 (USD Million)
9.2.3 Ages 65+
9.2.3.1 Ages 65+ market estimates and forecast, 2018 - 2030 (USD Million)
9.2 Population Screening Market: Age Movement Analysis
9.2.1 Age < 15
9.2.1.1 Age < 15 Market Estimates And Forecast, 2018 - 2030 (USD Million)
9.2.2 15-65
9.2.2.1 15-65 Market Estimates And Forecast, 2018 - 2030 (USD Million)
9.2.3 Ages 65+
9.2.3.1 Ages 65+ market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 10 Regional Business Analysis
10.1 Definition & Scope
10.2 Regional Market Share Analysis, 2021 & 2030
10.3 Regional Market Dashboard
10.4 Regional Market Snapshot
10.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
10.5.1 North America
10.5.2 Europe
10.5.3 Asia Pacific
10.5.4 Latin America
10.5.5 MEA
10.6 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
10.7 North America
10.7.1 North America Market Estimates And Forecast, 2018 - 2030 (USD MILLION)
10.7.2 U.S.
10.7.2.1 U.S. Population Screening Market, 2018 - 2030 (USD Million)
10.7.2.2 Key country Dynamics
10.7.2.3 Regulatory Framework
10.7.2.4 Competitive Scenario
10.7.2.5 Recent Developments
10.7.2.6 Investments Scenario
10.7.3 Canada
10.7.3.1 Canada Population Screening Market, 2018 - 2030 (USD Million)
10.7.3.2 Key country Dynamics
10.7.3.3 Regulatory Framework
10.7.3.4 Competitive Scenario
10.7.3.5 Recent Developments
10.7.3.6 Investments Scenario
10.8 Europe
10.8.1 Europe Population Screening Market, 2018 - 2030 (USD Million)
10.8.2 UK
10.8.2.1 UK Population Screening Market, 2018 - 2030 (USD Million)
10.8.2.2 Key country Dynamics
10.8.2.3 Regulatory Framework
10.8.2.4 Competitive Scenario
10.8.2.5 Recent Developments
10.8.2.6 Investments Scenario
10.8.3 Germany
10.8.3.1 Germany Population Screening Market, 2018 - 2030 (USD Million)
10.8.3.2 Key country Dynamics
10.8.3.3 Regulatory Framework
10.8.3.4 Competitive Scenario
10.8.3.5 Recent Developments
10.8.3.6 Investments Scenario
10.8.4 Spain
10.8.4.1 Spain Population Screening Market, 2018 - 2030 (USD Million)
10.8.4.2 Key country Dynamics
10.8.4.3 Regulatory Framework
10.8.4.4 Competitive Scenario
10.8.4.5 Recent Developments
10.8.4.6 Investments Scenario
10.8.5 France
10.8.5.1 France Population Screening Market, 2018 - 2030 (USD Million)
10.8.5.2 Key country Dynamics
10.8.5.3 Regulatory Framework
10.8.5.4 Competitive Scenario
10.8.5.5 Recent Developments
10.8.5.6 Investments Scenario
10.8.6 Italy
10.8.6.1 Italy Population Screening Market, 2018 - 2030 (USD Million)
10.8.6.2 Key country Dynamics
10.8.6.3 Regulatory Framework
10.8.6.4 Competitive Scenario
10.8.6.5 Recent Developments
10.8.6.6 Investments Scenario
10.8.7 Denmark
10.8.7.1 Denmark Population Screening Market, 2018 - 2030 (USD Million)
10.8.7.2 Key country Dynamics
10.8.7.3 Regulatory Framework
10.8.7.4 Competitive Scenario
10.8.7.5 Recent Developments
10.8.7.6 Investments Scenario
10.8.8 Sweden
10.8.8.1 Sweden Population Screening Market, 2018 - 2030 (USD Million)
10.8.8.2 Key country Dynamics
10.8.8.3 Regulatory Framework
10.8.8.4 Competitive Scenario
10.8.8.5 Recent Developments
10.8.8.6 Investments Scenario
10.8.9 Norway
10.8.9.1 Norway Population Screening Market, 2018 - 2030 (USD Million)
10.8.9.2 Key country Dynamics
10.8.9.3 Regulatory Framework
10.8.9.4 Competitive Scenario
10.8.9.5 Recent Developments
10.8.9.6 Investments Scenario
10.9 Asia Pacific
10.9.1 Asia-Pacific Population Screening Market, 2018 - 2030 (USD Million)
10.9.2 Japan
10.9.2.1 Japan Population Screening Market, 2018 - 2030 (Usd Million)
10.9.2.2 Key Country Dynamics
10.9.2.3 Regulatory Framework
10.9.2.4 Competitive Scenario
10.9.2.5 Recent Developments
10.9.2.6 Investments Scenario
10.9.3 China
10.9.3.1 China Population Screening Market, 2018 - 2030 (Usd Million)
10.9.3.2 Key Country Dynamics
10.9.3.3 Regulatory Framework
10.9.3.4 Competitive Scenario
10.9.3.5 Recent Developments
10.9.3.6 Investments Scenario
10.9.4 India
10.9.4.1 India Population Screening Market, 2018 - 2030 (Usd Million)
10.9.4.2 Key Country Dynamics
10.9.4.3 Regulatory Framework
10.9.4.4 Competitive Scenario
10.9.4.5 Recent Developments
10.9.4.6 Investments Scenario
10.9.5 South Korea
10.9.5.1 South Korea Population Screening Market, 2018 - 2030 (Usd Million)
10.9.5.2 Key Country Dynamics
10.9.5.3 Regulatory Framework
10.9.5.4 Competitive Scenario
10.9.5.5 Recent Developments
10.9.5.6 Investments Scenario
10.9.6 Thailand
10.9.6.1 Thailand Population Screening Market, 2018 - 2030 (Usd Million)
10.9.6.2 Key Country Dynamics
10.9.6.3 Regulatory Framework
10.9.6.4 Competitive Scenario
10.9.6.5 Recent Developments
10.9.6.6 Investments Scenario
10.9.7 Australia
10.9.7.1 Australia Population Screening Market, 2018 - 2030 (USD Million)
10.9.7.2 Key country Dynamics
10.9.7.3 Regulatory Framework
10.9.7.4 Competitive Scenario
10.9.7.5 Recent Developments
10.9.7.6 Investments Scenario
10.10 Latin America
10.10.1 Latin America Population Screening Market, 2018 - 2030 (USD Million)
10.10.2 Brazil
10.10.2.1 Brazil Population Screening Market, 2018 - 2030 (Usd Million)
10.10.2.2 Key Country Dynamics
10.10.2.3 Regulatory Framework
10.10.2.4 Competitive Scenario
10.10.2.5 Recent Developments
10.10.2.6 Investments Scenario
10.10.3 Mexico
10.10.3.1 Mexico Population Screening Market, 2018 - 2030 (Usd Million)
10.10.3.2 Key Country Dynamics
10.10.3.3 Regulatory Framework
10.10.3.4 Competitive Scenario
10.10.3.5 Recent Developments
10.10.3.6 Investments Scenario
10.10.4 Argentina
10.10.4.1 Argentina Population Screening Market, 2018 - 2030 (Usd Million)
10.10.4.2 Key Country Dynamics
10.10.4.3 Regulatory Framework
10.10.4.4 Competitive Scenario
10.10.4.5 Recent Developments
10.10.4.6 Investments Scenario
10.11 MEA
10.11.1 Mea Population Screening Market, 2018 - 2030 (Usd Million)
10.11.2 South Africa
10.11.2.1 South Africa Population Screening Market, 2018 - 2030 (Usd Million)
10.11.2.2 Key Country Dynamics
10.11.2.3 Regulatory Framework
10.11.2.4 Competitive Scenario
10.11.2.5 Recent Developments
10.11.2.6 Investments Scenario
10.11.3 Saudi Arabia
10.11.3.1 Saudi Arabia Population Screening Market, 2018 - 2030 (Usd Million)
10.11.3.2 Key Country Dynamics
10.11.3.3 Regulatory Framework
10.11.3.4 Competitive Scenario
10.11.3.5 Recent Developments
10.11.3.6 Investments Scenario
10.11.4 UAE
10.11.4.1 Uae Population Screening Market, 2018 - 2030 (Usd Million)
10.11.4.2 Key Country Dynamics
10.11.4.3 Regulatory Framework
10.11.4.4 Competitive Scenario
10.11.4.5 Recent Developments
10.11.4.6 Investments Scenario
10.11.5 Kuwait
10.11.5.1 Kuwait Population Screening Market, 2018 - 2030 (USD Million)
10.11.5.2 Key country Dynamics
10.11.5.3 Regulatory Framework
10.11.5.4 Competitive Scenario
10.11.5.5 Recent Developments
10.11.5.6 Investments Scenario
10.2 Regional Market Share Analysis, 2021 & 2030
10.3 Regional Market Dashboard
10.4 Regional Market Snapshot
10.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
10.5.1 North America
10.5.2 Europe
10.5.3 Asia Pacific
10.5.4 Latin America
10.5.5 MEA
10.6 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
10.7 North America
10.7.1 North America Market Estimates And Forecast, 2018 - 2030 (USD MILLION)
10.7.2 U.S.
10.7.2.1 U.S. Population Screening Market, 2018 - 2030 (USD Million)
10.7.2.2 Key country Dynamics
10.7.2.3 Regulatory Framework
10.7.2.4 Competitive Scenario
10.7.2.5 Recent Developments
10.7.2.6 Investments Scenario
10.7.3 Canada
10.7.3.1 Canada Population Screening Market, 2018 - 2030 (USD Million)
10.7.3.2 Key country Dynamics
10.7.3.3 Regulatory Framework
10.7.3.4 Competitive Scenario
10.7.3.5 Recent Developments
10.7.3.6 Investments Scenario
10.8 Europe
10.8.1 Europe Population Screening Market, 2018 - 2030 (USD Million)
10.8.2 UK
10.8.2.1 UK Population Screening Market, 2018 - 2030 (USD Million)
10.8.2.2 Key country Dynamics
10.8.2.3 Regulatory Framework
10.8.2.4 Competitive Scenario
10.8.2.5 Recent Developments
10.8.2.6 Investments Scenario
10.8.3 Germany
10.8.3.1 Germany Population Screening Market, 2018 - 2030 (USD Million)
10.8.3.2 Key country Dynamics
10.8.3.3 Regulatory Framework
10.8.3.4 Competitive Scenario
10.8.3.5 Recent Developments
10.8.3.6 Investments Scenario
10.8.4 Spain
10.8.4.1 Spain Population Screening Market, 2018 - 2030 (USD Million)
10.8.4.2 Key country Dynamics
10.8.4.3 Regulatory Framework
10.8.4.4 Competitive Scenario
10.8.4.5 Recent Developments
10.8.4.6 Investments Scenario
10.8.5 France
10.8.5.1 France Population Screening Market, 2018 - 2030 (USD Million)
10.8.5.2 Key country Dynamics
10.8.5.3 Regulatory Framework
10.8.5.4 Competitive Scenario
10.8.5.5 Recent Developments
10.8.5.6 Investments Scenario
10.8.6 Italy
10.8.6.1 Italy Population Screening Market, 2018 - 2030 (USD Million)
10.8.6.2 Key country Dynamics
10.8.6.3 Regulatory Framework
10.8.6.4 Competitive Scenario
10.8.6.5 Recent Developments
10.8.6.6 Investments Scenario
10.8.7 Denmark
10.8.7.1 Denmark Population Screening Market, 2018 - 2030 (USD Million)
10.8.7.2 Key country Dynamics
10.8.7.3 Regulatory Framework
10.8.7.4 Competitive Scenario
10.8.7.5 Recent Developments
10.8.7.6 Investments Scenario
10.8.8 Sweden
10.8.8.1 Sweden Population Screening Market, 2018 - 2030 (USD Million)
10.8.8.2 Key country Dynamics
10.8.8.3 Regulatory Framework
10.8.8.4 Competitive Scenario
10.8.8.5 Recent Developments
10.8.8.6 Investments Scenario
10.8.9 Norway
10.8.9.1 Norway Population Screening Market, 2018 - 2030 (USD Million)
10.8.9.2 Key country Dynamics
10.8.9.3 Regulatory Framework
10.8.9.4 Competitive Scenario
10.8.9.5 Recent Developments
10.8.9.6 Investments Scenario
10.9 Asia Pacific
10.9.1 Asia-Pacific Population Screening Market, 2018 - 2030 (USD Million)
10.9.2 Japan
10.9.2.1 Japan Population Screening Market, 2018 - 2030 (Usd Million)
10.9.2.2 Key Country Dynamics
10.9.2.3 Regulatory Framework
10.9.2.4 Competitive Scenario
10.9.2.5 Recent Developments
10.9.2.6 Investments Scenario
10.9.3 China
10.9.3.1 China Population Screening Market, 2018 - 2030 (Usd Million)
10.9.3.2 Key Country Dynamics
10.9.3.3 Regulatory Framework
10.9.3.4 Competitive Scenario
10.9.3.5 Recent Developments
10.9.3.6 Investments Scenario
10.9.4 India
10.9.4.1 India Population Screening Market, 2018 - 2030 (Usd Million)
10.9.4.2 Key Country Dynamics
10.9.4.3 Regulatory Framework
10.9.4.4 Competitive Scenario
10.9.4.5 Recent Developments
10.9.4.6 Investments Scenario
10.9.5 South Korea
10.9.5.1 South Korea Population Screening Market, 2018 - 2030 (Usd Million)
10.9.5.2 Key Country Dynamics
10.9.5.3 Regulatory Framework
10.9.5.4 Competitive Scenario
10.9.5.5 Recent Developments
10.9.5.6 Investments Scenario
10.9.6 Thailand
10.9.6.1 Thailand Population Screening Market, 2018 - 2030 (Usd Million)
10.9.6.2 Key Country Dynamics
10.9.6.3 Regulatory Framework
10.9.6.4 Competitive Scenario
10.9.6.5 Recent Developments
10.9.6.6 Investments Scenario
10.9.7 Australia
10.9.7.1 Australia Population Screening Market, 2018 - 2030 (USD Million)
10.9.7.2 Key country Dynamics
10.9.7.3 Regulatory Framework
10.9.7.4 Competitive Scenario
10.9.7.5 Recent Developments
10.9.7.6 Investments Scenario
10.10 Latin America
10.10.1 Latin America Population Screening Market, 2018 - 2030 (USD Million)
10.10.2 Brazil
10.10.2.1 Brazil Population Screening Market, 2018 - 2030 (Usd Million)
10.10.2.2 Key Country Dynamics
10.10.2.3 Regulatory Framework
10.10.2.4 Competitive Scenario
10.10.2.5 Recent Developments
10.10.2.6 Investments Scenario
10.10.3 Mexico
10.10.3.1 Mexico Population Screening Market, 2018 - 2030 (Usd Million)
10.10.3.2 Key Country Dynamics
10.10.3.3 Regulatory Framework
10.10.3.4 Competitive Scenario
10.10.3.5 Recent Developments
10.10.3.6 Investments Scenario
10.10.4 Argentina
10.10.4.1 Argentina Population Screening Market, 2018 - 2030 (Usd Million)
10.10.4.2 Key Country Dynamics
10.10.4.3 Regulatory Framework
10.10.4.4 Competitive Scenario
10.10.4.5 Recent Developments
10.10.4.6 Investments Scenario
10.11 MEA
10.11.1 Mea Population Screening Market, 2018 - 2030 (Usd Million)
10.11.2 South Africa
10.11.2.1 South Africa Population Screening Market, 2018 - 2030 (Usd Million)
10.11.2.2 Key Country Dynamics
10.11.2.3 Regulatory Framework
10.11.2.4 Competitive Scenario
10.11.2.5 Recent Developments
10.11.2.6 Investments Scenario
10.11.3 Saudi Arabia
10.11.3.1 Saudi Arabia Population Screening Market, 2018 - 2030 (Usd Million)
10.11.3.2 Key Country Dynamics
10.11.3.3 Regulatory Framework
10.11.3.4 Competitive Scenario
10.11.3.5 Recent Developments
10.11.3.6 Investments Scenario
10.11.4 UAE
10.11.4.1 Uae Population Screening Market, 2018 - 2030 (Usd Million)
10.11.4.2 Key Country Dynamics
10.11.4.3 Regulatory Framework
10.11.4.4 Competitive Scenario
10.11.4.5 Recent Developments
10.11.4.6 Investments Scenario
10.11.5 Kuwait
10.11.5.1 Kuwait Population Screening Market, 2018 - 2030 (USD Million)
10.11.5.2 Key country Dynamics
10.11.5.3 Regulatory Framework
10.11.5.4 Competitive Scenario
10.11.5.5 Recent Developments
10.11.5.6 Investments Scenario
Chapter 11 Competitive Analysis
11.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
11.2 Strategy Framework
11.3 Market Participation Categorization
11.4 Recent Developments & Impact Analysis, by Key Market Participants
11.5 Company Position Analysis
11.6 List of Distributors
11.6.1 Key Customers
11.6.2 Public Companies
11.6.3 Private Companies
11.7 Case Studies
11.7.1 Cost Analysis Of Cvd Patients With Screening Vs No Screening
11.7.2 Case Study: Population Health Screening
11.7.3 Case Study: Screening Of Raw Cases Samples Using The Agilent Quickprobe Gc/Ms System
11.7.4 Case Study: Evaluate The Performance Of Roche Cobas 4800 Hpv Test For Evaluating Hpv Tests For Screening
11.7.5 Case Study: Measurement Of Glucose And Hemoglobin In Diabetes
11.2 Strategy Framework
11.3 Market Participation Categorization
11.4 Recent Developments & Impact Analysis, by Key Market Participants
11.5 Company Position Analysis
11.6 List of Distributors
11.6.1 Key Customers
11.6.2 Public Companies
11.6.3 Private Companies
11.7 Case Studies
11.7.1 Cost Analysis Of Cvd Patients With Screening Vs No Screening
11.7.2 Case Study: Population Health Screening
11.7.3 Case Study: Screening Of Raw Cases Samples Using The Agilent Quickprobe Gc/Ms System
11.7.4 Case Study: Evaluate The Performance Of Roche Cobas 4800 Hpv Test For Evaluating Hpv Tests For Screening
11.7.5 Case Study: Measurement Of Glucose And Hemoglobin In Diabetes
Chapter 12 COMPANY PROFILES
12.1 Company Profiles
12.1.1 AGILENT TECHNOLOGIES, INC.
12.1.1.1 Company Overview
12.1.1.2 Financial Performance
12.1.1.3 Product Benchmarking
12.1.1.4 Strategic Initiatives
12.1.2 THERMO FISHER SCIENTIFIC, INC.
12.1.2.1 Company Overview
12.1.2.2 Financial performance
12.1.2.3 Product Benchmarking
12.1.2.4 Strategic Initiatives
12.1.3 QIAGEN
12.1.3.1 Company Overview
12.1.3.2 Financial performance
12.1.3.3 Product Benchmarking
12.1.3.4 Strategic Initiatives
12.1.4 F. HOFFMANN-LA ROCHE LTD
12.1.4.1 Company Overview
12.1.4.2 Financial performance
12.1.4.3 Product Benchmarking
12.1.4.4 Strategic Initiatives
12.1.5 QUEST DIAGNOSTICS
12.1.5.1 Company Overview
12.1.5.2 Financial performance
12.1.5.3 Product Benchmarking
12.1.5.4 Strategic Initiatives
12.1.6 ILLUMINA, INC
12.1.6.1 Company Overview
12.1.6.2 Financial performance
12.1.6.3 Product Benchmarking
12.1.6.4 Strategic Initiatives
12.1.7 ARUP LABORATORIES
12.1.7.1 Company Overview
12.1.7.2 Product Benchmarking
12.1.7.3 Strategic Initiatives
12.1.8 NOVOGENE CO., LTD.
12.1.8.1 Company Overview
12.1.8.2 Product Benchmarking
12.1.8.3 Strategic Initiatives
12.1.9 LGC LIMITED
12.1.9.1 Company Overview
12.1.9.2 Product Benchmarking
12.1.9.3 Strategic Initiatives
12.1.10 GENE BY GENE, LTD.
12.1.10.1 Company Overview
12.1.10.2 Product Benchmarking
12.1.1 AGILENT TECHNOLOGIES, INC.
12.1.1.1 Company Overview
12.1.1.2 Financial Performance
12.1.1.3 Product Benchmarking
12.1.1.4 Strategic Initiatives
12.1.2 THERMO FISHER SCIENTIFIC, INC.
12.1.2.1 Company Overview
12.1.2.2 Financial performance
12.1.2.3 Product Benchmarking
12.1.2.4 Strategic Initiatives
12.1.3 QIAGEN
12.1.3.1 Company Overview
12.1.3.2 Financial performance
12.1.3.3 Product Benchmarking
12.1.3.4 Strategic Initiatives
12.1.4 F. HOFFMANN-LA ROCHE LTD
12.1.4.1 Company Overview
12.1.4.2 Financial performance
12.1.4.3 Product Benchmarking
12.1.4.4 Strategic Initiatives
12.1.5 QUEST DIAGNOSTICS
12.1.5.1 Company Overview
12.1.5.2 Financial performance
12.1.5.3 Product Benchmarking
12.1.5.4 Strategic Initiatives
12.1.6 ILLUMINA, INC
12.1.6.1 Company Overview
12.1.6.2 Financial performance
12.1.6.3 Product Benchmarking
12.1.6.4 Strategic Initiatives
12.1.7 ARUP LABORATORIES
12.1.7.1 Company Overview
12.1.7.2 Product Benchmarking
12.1.7.3 Strategic Initiatives
12.1.8 NOVOGENE CO., LTD.
12.1.8.1 Company Overview
12.1.8.2 Product Benchmarking
12.1.8.3 Strategic Initiatives
12.1.9 LGC LIMITED
12.1.9.1 Company Overview
12.1.9.2 Product Benchmarking
12.1.9.3 Strategic Initiatives
12.1.10 GENE BY GENE, LTD.
12.1.10.1 Company Overview
12.1.10.2 Product Benchmarking
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global Population Screening Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 6 Global Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 7 Global Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 8 Global Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 9 Global Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 10 Global Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 11 North America Population Screening Market, By Country, 2018 - 2030, (USD Million)
Table 12 North America Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 13 North America Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 14 North America Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 15 North America Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 16 North America Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 17 North America Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 18 U.S. Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 19 U.S. Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 20 U.S. Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 21 U.S. Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 22 U.S. Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 23 U.S. Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 24 Canada Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 25 Canada Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 26 Canada Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 27 Canada Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 28 Canada Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 29 Canada Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 30 Europe Population Screening Market, By Country, 2018 - 2030, (USD Million)
Table 31 Europe Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 32 Europe Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 33 Europe Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 34 Europe Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 35 Europe Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 36 Europe Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 37 UK Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 38 UK Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 39 UK Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 40 UK Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 41 UK Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 42 UK Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 43 Germany Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 44 Germany Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 45 Germany Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 46 Germany Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 47 Germany Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 48 Germany Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 49 France Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 50 France Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 51 France Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 52 France Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 53 France Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 54 France Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 55 Spain Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 56 Spain Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 57 Spain Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 58 Spain Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 59 Spain Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 60 Spain Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 61 Italy Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 62 Italy Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 63 Italy Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 64 Italy Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 65 Italy Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 66 Italy Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 67 Denmark Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 68 Denmark Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 69 Denmark Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 70 Denmark Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 71 Denmark Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 72 Denmark Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 73 Sweden Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 74 Sweden Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 75 Sweden Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 76 Sweden Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 77 Sweden Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 78 Sweden Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 79 Norway Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 80 Norway Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 81 Norway Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 82 Norway Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 83 Norway Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 84 Norway Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 85 Asia Pacific Population Screening Market, By Country, 2018 - 2030, (USD Million)
Table 86 Asia Pacific Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 87 Asia Pacific Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 88 Asia Pacific Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 89 Asia Pacific Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 90 Asia Pacific Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 91 Asia Pacific Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 92 Japan Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 93 Japan Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 94 Japan Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 95 Japan Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 96 Japan Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 97 Japan Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 98 China Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 99 China Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 100 China Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 101 China Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 102 China Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 103 China Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 104 Australia Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 105 Australia Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 106 Australia Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 107 Australia Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 108 Australia Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 109 Australia Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 110 Thailand Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 111 Thailand Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 112 Thailand Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 113 Thailand Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 114 Thailand Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 115 Thailand Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 116 India Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 117 India Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 118 India Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 119 India Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 120 India Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 121 India Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 122 South Korea Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 123 South Korea Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 124 South Korea Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 125 South Korea Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 126 South Korea Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 127 South Korea Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 128 Latin America Population Screening Market, By Country, 2018 - 2030, (USD Million)
Table 129 Latin America Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 130 Latin America Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 131 Latin America Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 132 Latin America Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 133 Latin America Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 134 Latin America Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 135 Mexico Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 136 Mexico Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 137 Mexico Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 138 Mexico Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 139 Mexico Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 140 Mexico Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 141 Brazil Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 142 Brazil Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 143 Brazil Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 144 Brazil Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 145 Brazil Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 146 Brazil Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 147 Argentina Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 148 Argentina Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 149 Argentina Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 150 Argentina Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 151 Argentina Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 152 Argentina Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 153 MEA Population Screening Market, By Country, 2018 - 2030, (USD Million)
Table 154 MEA Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 155 MEA Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 156 MEA Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 157 MEA Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 158 MEA Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 159 MEA Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 160 South Africa Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 161 South Africa Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 162 South Africa Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 163 South Africa Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 164 South Africa Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 165 South Africa Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 166 South Africa Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 167 Saudi Arabia Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 168 Saudi Arabia Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 169 Saudi Arabia Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 170 Saudi Arabia Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 171 Saudi Arabia Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 172 Saudi Arabia Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 173 Saudi Arabia Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 174 UAE Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 175 UAE Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 176 UAE Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 177 UAE Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 178 UAE Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 179 UAE Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 180 Kuwait Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 181 Kuwait Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 182 Kuwait Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 183 Kuwait Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 184 Kuwait Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 185 Kuwait Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global Population Screening Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 6 Global Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 7 Global Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 8 Global Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 9 Global Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 10 Global Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 11 North America Population Screening Market, By Country, 2018 - 2030, (USD Million)
Table 12 North America Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 13 North America Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 14 North America Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 15 North America Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 16 North America Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 17 North America Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 18 U.S. Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 19 U.S. Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 20 U.S. Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 21 U.S. Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 22 U.S. Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 23 U.S. Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 24 Canada Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 25 Canada Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 26 Canada Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 27 Canada Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 28 Canada Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 29 Canada Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 30 Europe Population Screening Market, By Country, 2018 - 2030, (USD Million)
Table 31 Europe Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 32 Europe Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 33 Europe Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 34 Europe Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 35 Europe Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 36 Europe Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 37 UK Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 38 UK Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 39 UK Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 40 UK Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 41 UK Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 42 UK Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 43 Germany Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 44 Germany Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 45 Germany Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 46 Germany Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 47 Germany Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 48 Germany Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 49 France Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 50 France Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 51 France Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 52 France Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 53 France Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 54 France Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 55 Spain Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 56 Spain Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 57 Spain Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 58 Spain Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 59 Spain Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 60 Spain Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 61 Italy Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 62 Italy Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 63 Italy Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 64 Italy Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 65 Italy Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 66 Italy Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 67 Denmark Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 68 Denmark Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 69 Denmark Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 70 Denmark Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 71 Denmark Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 72 Denmark Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 73 Sweden Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 74 Sweden Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 75 Sweden Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 76 Sweden Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 77 Sweden Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 78 Sweden Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 79 Norway Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 80 Norway Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 81 Norway Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 82 Norway Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 83 Norway Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 84 Norway Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 85 Asia Pacific Population Screening Market, By Country, 2018 - 2030, (USD Million)
Table 86 Asia Pacific Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 87 Asia Pacific Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 88 Asia Pacific Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 89 Asia Pacific Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 90 Asia Pacific Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 91 Asia Pacific Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 92 Japan Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 93 Japan Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 94 Japan Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 95 Japan Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 96 Japan Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 97 Japan Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 98 China Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 99 China Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 100 China Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 101 China Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 102 China Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 103 China Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 104 Australia Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 105 Australia Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 106 Australia Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 107 Australia Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 108 Australia Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 109 Australia Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 110 Thailand Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 111 Thailand Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 112 Thailand Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 113 Thailand Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 114 Thailand Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 115 Thailand Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 116 India Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 117 India Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 118 India Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 119 India Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 120 India Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 121 India Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 122 South Korea Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 123 South Korea Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 124 South Korea Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 125 South Korea Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 126 South Korea Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 127 South Korea Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 128 Latin America Population Screening Market, By Country, 2018 - 2030, (USD Million)
Table 129 Latin America Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 130 Latin America Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 131 Latin America Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 132 Latin America Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 133 Latin America Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 134 Latin America Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 135 Mexico Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 136 Mexico Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 137 Mexico Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 138 Mexico Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 139 Mexico Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 140 Mexico Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 141 Brazil Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 142 Brazil Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 143 Brazil Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 144 Brazil Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 145 Brazil Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 146 Brazil Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 147 Argentina Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 148 Argentina Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 149 Argentina Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 150 Argentina Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 151 Argentina Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 152 Argentina Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 153 MEA Population Screening Market, By Country, 2018 - 2030, (USD Million)
Table 154 MEA Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 155 MEA Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 156 MEA Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 157 MEA Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 158 MEA Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 159 MEA Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 160 South Africa Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 161 South Africa Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 162 South Africa Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 163 South Africa Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 164 South Africa Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 165 South Africa Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 166 South Africa Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 167 Saudi Arabia Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 168 Saudi Arabia Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 169 Saudi Arabia Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 170 Saudi Arabia Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 171 Saudi Arabia Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 172 Saudi Arabia Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 173 Saudi Arabia Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 174 UAE Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 175 UAE Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 176 UAE Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 177 UAE Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 178 UAE Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 179 UAE Population Screening Market, By Age, 2018 - 2030 (USD Million)
Table 180 Kuwait Population Screening Market, By Geography, 2018 - 2030 (USD Million)
Table 181 Kuwait Population Screening Market, By Product, 2018 - 2030 (USD Million)
Table 182 Kuwait Population Screening Market, By Business, 2018 - 2030 (USD Million)
Table 183 Kuwait Population Screening Market, By Gender, 2018 - 2030 (USD Million)
Table 184 Kuwait Population Screening Market, By Type, 2018 - 2030 (USD Million)
Table 185 Kuwait Population Screening Market, By Age, 2018 - 2030 (USD Million)
List of Figures
FIG. 1 Population screening market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow approach
Fig. 10 Market snapshot (2022) (USD Million)
Fig. 11 Segment Snapshot (2022) (USD Million)
Fig. 12 Segment Snapshot (2022) (USD Million)
Fig. 13 Segment Snapshot (2022) (USD Million)
Fig. 14 Market Outlook (2022) (USD Million)
Fig. 15 Penetration & growth prospect mapping
Fig. 16 Population screening market driver impact
Fig. 17 Global cancer cases projection, 2020-2030 (Number of newly registered cases)
Fig. 18 Distinguishing screening from early diagnosis of cancer according to symptom onset
Fig. 19 Elderly population total, % of the global population
Fig. 20 Population screening market restraint impact
Fig. 21 PESTEL analysis
Fig. 22 Porter’s Five Forces analysis
Fig. 23 Population screening geography outlook: Key takeaways
Fig. 24 Population screening market: Geography movement analysis
Fig. 25 Nation market 2018 - 2030 (USD Million)
Fig. 26 State market, 2018 - 2030 (USD Million)
Fig. 27 Population screening product analysis outlook: Key takeaways
Fig. 28 Population screening market: Product movement analysis
Fig. 29 Hardware and Equipment market, 2018 - 2030 (USD Million)
Fig. 30 Testing/lab (services) market, 2018 - 2030 (USD Million)
Fig. 31 Analytics/interpretation market, 2018 - 2030 (USD Million)
Fig. 32 Population screening business outlook: Key takeaways
Fig. 33 Population screening market: business analysis
Fig. 34 Hospitals market, 2018 - 2030 (USD Million)
Fig. 35 Research institute market, 2018 - 2030 (USD Million)
Fig. 36 Diagnostic labs market, 2018 - 2030 (USD Million)
Fig. 37 Population screening gender outlook: Key takeaways
Fig. 38 Population screening market: Gender analysis
Fig. 39 Male market, 2018 - 2030 (USD Million)
Fig. 40 Current screening statistics CDC (2022)
Fig. 41 Female market, 2018 - 2030 (USD Million)
Fig. 42 Population screening type outlook: Key takeaways
Fig. 43 Population screening market: Type analysis
Fig. 44 Mass market, 2018 - 2030 (USD Million)
Fig. 45 Premium market, 2018 - 2030 (USD Million)
Fig. 46 Population screening age outlook: Key takeaways
Fig. 47 Population screening market: Age analysis
Fig. 48 Ages 15 market, 2018 - 2030 (USD Million)
Fig. 49 15-65 years market, 2018 - 2030 (USD Million)
Fig. 50 Ages 65+ years market, 2018 - 2030 (USD Million)
Fig. 51 Regional snapshot, 2021 & 2030
Fig. 52 Regional marketplace: Key takeaways
Fig. 53 Crude & effective coverage for cervical cancer screening across women aged 25 - 64
Fig. 54 Global population screening market, 2018 - 2030 (USD Million)
Fig. 55 North America population screening market, 2018 - 2030 (USD Million)
Fig. 56 Europe population screening market, 2018 - 2030 (USD Million)
Fig. 57 Asia Pacific population screening market, 2018 - 2030 (USD Million)
Fig. 58 Latin America population screening market, 2018 - 2030 (USD Million)
Fig. 59 Middle East and Africa population screening market, 2018 - 2030 (USD Million)
Fig. 60 GCC population screening market, 2018 - 2030 (USD Million)
Fig. 61 Rest of GCC population screening market, 2018 - 2030 (USD Million)
Fig. 62 UAE population screening market, 2018 - 2030 (USD Million)
Fig. 63 Australia population screening market, 2018 - 2030 (USD Million)
Fig. 64 Percentage of screening for chronic diseases in 2017 and 2020
Fig. 65 Singapore population screening market, 2018 - 2030 (USD Million)
Fig. 66 UK population screening market, 2018 - 2030 (USD Million)
Fig. 67 Thailand population screening market, 2018 - 2030 (USD Million)
Fig. 68 ASEAN countries population screening market, 2018 - 2030 (USD Million)
Fig. 69 Recent company/competition categorization
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow approach
Fig. 10 Market snapshot (2022) (USD Million)
Fig. 11 Segment Snapshot (2022) (USD Million)
Fig. 12 Segment Snapshot (2022) (USD Million)
Fig. 13 Segment Snapshot (2022) (USD Million)
Fig. 14 Market Outlook (2022) (USD Million)
Fig. 15 Penetration & growth prospect mapping
Fig. 16 Population screening market driver impact
Fig. 17 Global cancer cases projection, 2020-2030 (Number of newly registered cases)
Fig. 18 Distinguishing screening from early diagnosis of cancer according to symptom onset
Fig. 19 Elderly population total, % of the global population
Fig. 20 Population screening market restraint impact
Fig. 21 PESTEL analysis
Fig. 22 Porter’s Five Forces analysis
Fig. 23 Population screening geography outlook: Key takeaways
Fig. 24 Population screening market: Geography movement analysis
Fig. 25 Nation market 2018 - 2030 (USD Million)
Fig. 26 State market, 2018 - 2030 (USD Million)
Fig. 27 Population screening product analysis outlook: Key takeaways
Fig. 28 Population screening market: Product movement analysis
Fig. 29 Hardware and Equipment market, 2018 - 2030 (USD Million)
Fig. 30 Testing/lab (services) market, 2018 - 2030 (USD Million)
Fig. 31 Analytics/interpretation market, 2018 - 2030 (USD Million)
Fig. 32 Population screening business outlook: Key takeaways
Fig. 33 Population screening market: business analysis
Fig. 34 Hospitals market, 2018 - 2030 (USD Million)
Fig. 35 Research institute market, 2018 - 2030 (USD Million)
Fig. 36 Diagnostic labs market, 2018 - 2030 (USD Million)
Fig. 37 Population screening gender outlook: Key takeaways
Fig. 38 Population screening market: Gender analysis
Fig. 39 Male market, 2018 - 2030 (USD Million)
Fig. 40 Current screening statistics CDC (2022)
Fig. 41 Female market, 2018 - 2030 (USD Million)
Fig. 42 Population screening type outlook: Key takeaways
Fig. 43 Population screening market: Type analysis
Fig. 44 Mass market, 2018 - 2030 (USD Million)
Fig. 45 Premium market, 2018 - 2030 (USD Million)
Fig. 46 Population screening age outlook: Key takeaways
Fig. 47 Population screening market: Age analysis
Fig. 48 Ages 15 market, 2018 - 2030 (USD Million)
Fig. 49 15-65 years market, 2018 - 2030 (USD Million)
Fig. 50 Ages 65+ years market, 2018 - 2030 (USD Million)
Fig. 51 Regional snapshot, 2021 & 2030
Fig. 52 Regional marketplace: Key takeaways
Fig. 53 Crude & effective coverage for cervical cancer screening across women aged 25 - 64
Fig. 54 Global population screening market, 2018 - 2030 (USD Million)
Fig. 55 North America population screening market, 2018 - 2030 (USD Million)
Fig. 56 Europe population screening market, 2018 - 2030 (USD Million)
Fig. 57 Asia Pacific population screening market, 2018 - 2030 (USD Million)
Fig. 58 Latin America population screening market, 2018 - 2030 (USD Million)
Fig. 59 Middle East and Africa population screening market, 2018 - 2030 (USD Million)
Fig. 60 GCC population screening market, 2018 - 2030 (USD Million)
Fig. 61 Rest of GCC population screening market, 2018 - 2030 (USD Million)
Fig. 62 UAE population screening market, 2018 - 2030 (USD Million)
Fig. 63 Australia population screening market, 2018 - 2030 (USD Million)
Fig. 64 Percentage of screening for chronic diseases in 2017 and 2020
Fig. 65 Singapore population screening market, 2018 - 2030 (USD Million)
Fig. 66 UK population screening market, 2018 - 2030 (USD Million)
Fig. 67 Thailand population screening market, 2018 - 2030 (USD Million)
Fig. 68 ASEAN countries population screening market, 2018 - 2030 (USD Million)
Fig. 69 Recent company/competition categorization
Companies Mentioned
- AGILENT TECHNOLOGIES, INC.
- THERMO FISHER SCIENTIFIC, INC.
- QIAGEN
- F. HOFFMANN-LA ROCHE LTD
- QUEST DIAGNOSTICS
- ILLUMINA, INC
- ARUP LABORATORIES
- NOVOGENE CO., LTD.
- LGC LIMITED
- GENE BY GENE, LTD.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | December 2022 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 25715.15 Million |
| Forecasted Market Value ( USD | $ 38200 Million |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
